The pharmaceutical industry is rapidly evolving, with increasing demand for high-performance Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, is a key example of this trend. To fulfill https://bookmarkusers.com/story20280448/prominent-us-based-dulaglutide-api-manufacturing-services